Pharm prime vendor fleet

DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,672.13 by the Defense Logistics Agency on January 15, 2026. This firm fixed-price delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was established on November 13, 2025, with a $499.999 billion ceiling and completion date of December 31, 2036. The delivery order carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The contract enables the Defense Logistics Agency to procure a comprehensive range of pharmaceutical products and medical consumables, including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals to support Department of Defense healthcare operations.

DMS Pharmaceutical Group's selection as a prime vendor under the PPV-G GEN V program positions the company as a critical supplier within the federal military medical supply chain, with capacity to fulfill diverse and specialized pharmaceutical requirements across DoD healthcare facilities worldwide. The broader PPV-G GEN V acquisition strategy represents a $30.3 billion government-wide initiative structured with multiple regional prime vendor contractors. The contractor's established performance on numerous prior delivery orders and comprehensive product portfolio—spanning oncology treatments, immunosuppressants, biologics, vaccines, emergency medications, and routine pharmaceuticals—demonstrates its capability to meet the specialized demands of military healthcare operations. This delivery order is part of ongoing pharmaceutical procurement operations supporting federal defense and military medical missions.